Status:

UNKNOWN

The Effects of Aronia Melanocarpa Extract on Obese Individuals With Impaired Fasting Blood Glucose

Lead Sponsor:

Peking Union Medical College Hospital

Conditions:

Obesity

Eligibility:

All Genders

18-40 years

Phase:

NA

Brief Summary

Obesity is closely related to many chronic diseases such as hypertension, coronary heart disease, hyperlipidemia, type 2 diabetes, fatty liver, certain types of tumors, etc, which are associated with ...

Eligibility Criteria

Inclusion

  • Aged 18-40 years
  • Simple obese individuals with stable body weight in the last three months before enrollment (28.0kg/m2 ≤ BMI \<35.0kg/m2)
  • Impaired fasting blood glucose: Within the last three months before enrollment, the venous fasting blood glucose was between 6.1 and 7.0 mmol/L, and the 2-hour postprandial blood glucose was\<7.8 mmol/L and the glycated hemoglobin (HbA1c) was \< 6.5%

Exclusion

  • Diagnosed patients with diabetes or those who use hypoglycemic drugs
  • Patients with concomitant hyperthyroidism or hypothyroidism, or those taking thyroxine tablets
  • Those who apply glucocorticoids within 12 weeks
  • Individuals with suspected renal dysfunction (female: serum creatinine ≥ 84 µ mol/L; male: serum creatinine ≥ 104 µ mol/L) or suspected liver dysfunction (elevated transaminase \>3 times normal or cirrhosis)
  • Secondary obesity (such as thalamic diseases, pituitary diseases, Cushing's syndrome, etc.)
  • Previous weight loss surgeries
  • Pregnant or lactating individuals
  • Individuals with confirmed mental illness or eating disorders
  • Women with polycystic ovary syndrome
  • Individuals who are allergic or intolerant to experimental products
  • Lactose intolerant individuals
  • Those who have taken probiotics and/or probiotic drugs or supplements within one month before enrollment
  • Those who fail to use intervention agents according to the study protocol or have severely incomplete visit records

Key Trial Info

Start Date :

October 7 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 30 2025

Estimated Enrollment :

72 Patients enrolled

Trial Details

Trial ID

NCT06057389

Start Date

October 7 2023

End Date

December 30 2025

Last Update

September 28 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.